Literature DB >> 24705255

Early infection of hip joint prosthesis by Clostridium difficile in an HIV-1 infected patient.

L Brassinne1, H Rodriguez-Villalobos2, S Jonckheere3, J E Dubuc4, J C Yombi5.   

Abstract

Anaerobes are less frequently described as causative pathogen of prosthetic joint infection (PJI). We report the first case of early PJI after hip arthroplasty due to Clostridium difficile in a diabetic and HIV-1 infected patient with bacteremia. Our patient was successfully treated through surgical debridement and prosthesis retention combined with targeted antibiotic therapy.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anaerobes prosthetic infection; Clostridium difficile; HIV; Immunocompromised infection; Prosthetic joint infection

Mesh:

Substances:

Year:  2014        PMID: 24705255     DOI: 10.1016/j.anaerobe.2014.03.007

Source DB:  PubMed          Journal:  Anaerobe        ISSN: 1075-9964            Impact factor:   3.331


  4 in total

1.  First case of periprosthetic joint infection due to Clostridioides difficile in China.

Authors:  Yang Song; Hong Yi Shao; Xiang Cheng; Yu Guo
Journal:  BMC Infect Dis       Date:  2021-05-21       Impact factor: 3.090

2.  Clostridium difficile septic arthritis and periprosthetic joint infection in a patient with acute lymphoblastic leukaemia, T-/B-lymphocytopenia and hypogammaglobulinemia - a case report and review of the literature.

Authors:  Daniel Karczewski; Maximilian Müllner; Carsten Perka; Michael Müller
Journal:  Access Microbiol       Date:  2021-05-10

3.  Bacteremia and Septic Arthritis due to a Nontoxigenic Strain of Clostridium difficile in a Patient With Sickle Cell Disease.

Authors:  Emilie Hill; Adrienne D Workman; Francesca Lee; Rita Hollaway; Dominick Cavuoti; Bonnie C Prokesch
Journal:  Open Forum Infect Dis       Date:  2018-01-02       Impact factor: 3.835

4.  A case report of a deep surgical site infection with Terrisporobacter glycolicus/T. Mayombei and review of the literature.

Authors:  Matthew P Cheng; Marc-Christian Domingo; Simon Lévesque; Cedric P Yansouni
Journal:  BMC Infect Dis       Date:  2016-09-29       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.